antihemophilic factor

(redirected from Xyntha)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Xyntha: Kogenate, Advate

an·ti·he·mo·phil·ic factor

 (ăn′tē-hē′mə-fĭl′ĭk, ăn′tī-)
n. Abbr. AHF
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.antihemophilic factor - a coagulation factor (trade name Hemofil) whose absence is associated with hemophilia Aantihemophilic factor - a coagulation factor (trade name Hemofil) whose absence is associated with hemophilia A
clotting factor, coagulation factor - any of the factors in the blood whose actions are essential for blood coagulation
References in periodicals archive ?
ReFacto AF is the trademark for the product in Europe and XYNTHA is the registered trademark in the US, Canada, Australia and other markets.
Science company Pfizer Inc (NYSE:PFE) stated on Monday the receipt of approval from the US Food and Drug Administration (FDA) for the use of a prefilled dual-chamber syringe for administration of XYNTHA Antihemophilic Factor (Recombinant) Plasma/Albumin-Free for haemophilia A, an inherited disease that prevents the blood from clotting properly.
The new treatment, called Xyntha Antihemophilic Factor (Recombinant) Plasma/Albumin Free, is a genetically engineered version of factor VIII, a protein essential for the clotting of blood.
Wyeth (Madison NJ) was cleared to sell its Xyntha drug to prevent and control bleeding in patients with hemophilia.
9 August 2010 - US-based biopharmaceutical company Pfizer Inc (NYSE: PFE) announced today that the US Food and Drug Administration (FDA) has granted approval for the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients.